Capricor Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $2,261 | $3,971 | $4,906 | $12,088 |
Gross Profit | 2,261 | 3,614 | 4,575 | 11,780 |
EBITDA | -12,648 | -11,234 | -9,934 | -973 |
EBIT | -13,009 | -11,591 | -10,265 | -1,281 |
Net Income | -12,556,728 | -10,999 | -9,794 | -762 |
Net Change In Cash | 2,261 | 3,971 | 4,906 | 12,088 |
Free Cash Flow | -25,863,183 | -12,369 | -1,932 | -12,323 |
Cash | 68,377 | 10,688 | 6,214 | 14,694 |
Basic Shares | 33,090 | 31,841 | 31,354 | 30,664 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $25,178 | $2,548 | $244 | $310 |
Gross Profit | 24,109 | 1,854 | -8,146 | |
EBITDA | -23,008 | -29,164 | -20,692 | -13,546 |
EBIT | -24,077 | -29,859 | -20,938 | -13,689 |
Net Income | -22,287 | -29,018 | -19,409 | -13,480 |
Net Change In Cash | 25,178 | 2,548 | 244 | 310 |
Cost of Revenue | -25,282 | 2,219 | 28,766 | |
Free Cash Flow | -27,644 | 1,556 | -18,005 | -10,602 |
Cash | 14,694 | 9,603 | 34,885 | 32,665 |
Basic Shares | 26,778 | 24,552 | 23,089 | 15,571 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.38 |
2024-06-30 | -$0.35 |
2024-03-31 | -$0.31 |
2023-12-31 | -$0.02 |
